• OPEN AN ACCOUNT
Indian Indices
Nifty
24,870.10 -213.65
(-0.85%)
Sensex
81,306.85 -693.86
( -0.85%)
Bank Nifty
55,149.40 -606.05
( -1.09%)
Nifty IT
35,440.85 -283.05
( -0.79%)
Global Indices
Nasdaq
45,658.64 852.13
(1.90%)
Dow Jones
6,488.44 97.27
(1.52%)
Hang Seng
42,587.47 -22.70
(-0.05%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.17 0.12
(0.14%)
EUR-INR
101.39 0.01
(0.01%)
GBP-INR
117.16 -0.12
(-0.11%)
JPY-INR
0.59 0.00
(-0.18%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
16.5329749
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
153.44
34.25
EPS(TTM)
Face Value()
Div & Yield %
0.16
10
0
 

Orient Tradelink Ltd - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations & Disclosures Requirements) Regulations 2015
May 29,2025
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended this is to inform you that the Board of Directors of Orient Tradelink Limited at their meeting held on Thursday 29th May 2025 at the Corporate Office of the Company at 141-A Ground Floor Shahpur Jat Village New Delhi Delhi - 110049 India has inter alia considered and approved the following matter(s): 1. The Annual Audited Standalone Financial Results of the Company for the quarter and financial year ended on 31st March 2025. 2. Considered and taken on record of the resignation of Dr. Balakrishna Ramarao Maddur from the post of Independent Director of the Company. 3. Considered and taken on record of the resignation of Mr. Akash Toshniwal from the post of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company.